Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKD (SPIRO-CKD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02502981
Recruitment Status : Unknown
Verified January 2018 by Dr JN Townend, University Hospital Birmingham.
Recruitment status was:  Active, not recruiting
First Posted : July 20, 2015
Last Update Posted : January 19, 2018
Sponsor:
Collaborators:
Royal Free Hospital NHS Foundation Trust
University of Edinburgh
University of Cambridge
Information provided by (Responsible Party):
Dr JN Townend, University Hospital Birmingham

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : February 2018
Estimated Study Completion Date : May 2018
Publications of Results:
Other Publications: